Sanmed Biotech
Latest round
- Series B
Last raised
- Apr 2021
Total raised
- $46M
Investors
- 1
About Sanmed Biotech
Founded in 2016 in Zhuhai, China, Sanmed Biotech focuses on liquid biopsy technologies., Ltd. specializes in liquid biopsy technologies aimed at enhancing the early detection and management of cancer, particularly lung cancer. The company's core product, the LiquidBiopsy system, is an automated platform that efficiently isolates and enriches circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) from blood samples. This technology enables precise molecular diagnostics without the need for whole genome amplification, allowing for seamless integration with various downstream sequencing techniques. The primary end users of these products include healthcare providers and institutions looking to improve cancer patient outcomes through early intervention and targeted treatments.Zhuhai Sanmed Biological Diagnostics operates through direct sales of its liquid biopsy systems and associated diagnostic services to hospitals and research institutions. Revenue is generated from the sale of its flagship LiquidBiopsy system, which is complemented by ongoing service agreements and consumables linked to the technology. The transaction structure typically involves direct sales to healthcare providers, along with partnerships that facilitate broader distribution and usage of its products. The company’s pricing strategy is designed to align with the healthcare sector’s needs, emphasizing cost-effectiveness and value for early cancer detection solutions. The company plans to launch new diagnostic products aimed at improving cancer detection capabilities by the end of 2023. Additionally, Sanmed Biotech is targeting expansion into Portuguese-speaking countries to enhance its market presence.
Who invested in Sanmed Biotech
1 investor across 1 round
See all investors in Sanmed Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 2, 2021
Amount
$46M
Investors
Questions about Sanmed Biotech
Who invested in Sanmed Biotech?
Sanmed Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanmed Biotech raised?
Sanmed Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sanmed Biotech last raise money?
Sanmed Biotech's most recent round on record is a Series B, in Apr 2021.
What does Sanmed Biotech do?
Founded in 2016 in Zhuhai, China, Sanmed Biotech focuses on liquid biopsy technologies.
Where is Sanmed Biotech headquartered?
Sanmed Biotech is headquartered in Zhuhai, China.
Which VCs invest in companies like Sanmed Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sanmed Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sanmed Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.